Genentech, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Genentech, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4478
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Genentech, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Genentech, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Genentech, Inc. (Genentech), a wholly-owned subsidiary of the Roche Group, is a biotechnology company. It primarily discoves, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. Some of the products of the company inlcude Activase, Boniva Tablets, Cotellic, Erivedge, Fuzeon, Gazyva, Hemlibra, Invirase, Klonopin, Lucentis, Nutropin AQ, Ocrevus, Pegasys, Rituxan, Rocephin, Tecentriq, Valium, Xeloda and Zelboraf. The company offers its products with a focus on the areas of oncology, immunology, neuroscience, metabolism, ophthalmology and infectious disease and manages its manufacturing facilities and distribution center in California and Oregon, the US. Genentech is headquartered in South San Francisco, California, the US.

Scope

- Detailed information on Genentech, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Genentech, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Genentech, Inc. including a breakdown and examination of key business segments
- Intelligence on Genentech, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Genentech, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Genentech, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Genentech, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Genentech, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Genentech, Inc.: Company Overview 8
Genentech, Inc.: Overview and Key Facts 8
Genentech, Inc.: Overview 8
Genentech, Inc.: Key Facts 8
Genentech, Inc.: Key Employees 9
Genentech, Inc.: Key Employee Biographies 10
Genentech, Inc.: Major Products and Services 11
Genentech, Inc.: Company History 12
Genentech, Inc.: Locations and Subsidiaries 18
Genentech, Inc.: Key Competitors 19
Genentech, Inc.: Company Analysis 20
Genentech, Inc.: Business Description 20
Genentech, Inc.: SWOT Analysis 21
Genentech, Inc.: SWOT Overview 21
Genentech, Inc.: Strengths 21
Genentech, Inc.: Weaknesses 21
Genentech, Inc.: Opportunities 22
Genentech, Inc.: Threats 23
Genentech, Inc.: Corporate Financial Deals Activity 24
Genentech, Inc.: Financial Deals Overview 24
Genentech, Inc.: Targets and Partners 26
Genentech, Inc.: Top Deals 2014 – 2018YTD* 28
Genentech, Inc.: Mergers and Acquisitions 29
Genentech, Inc.: Partnership 30
Genentech, Inc.: Recent Developments 31
Genentech, Inc.: News and Events Summary 31
Genentech, Inc.: Contracts 35
Genentech, Inc.: Corporate Governance 35
Genentech, Inc.: Financial Deals 36
Genentech, Inc.: Market Developments 36
Genentech, Inc.: Regulatory and Legal Events 39
Appendix 41
Contact Us 41
Methodology 41
About MarketLine 42

List of Tables
Table 1: Genentech, Inc.: Key Facts
Table 2: Genentech, Inc.: Key Employees
Table 3: Genentech, Inc.: Locations and Subsidiaries
Table 4: Genentech, Inc.: Key Competitors
Table 5: Genentech, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Genentech, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Genentech, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Genentech, Inc.: Targets and Partners
Table 9: Genentech, Inc.: Top Deals 2014 - 2018YTD*
Table 10: Genentech, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Genentech, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 12: Genentech, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: Genentech, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 14: Genentech, Inc.: News and Events Summary
Table 15: Genentech, Inc.: Contracts
Table 16: Genentech, Inc.: Corporate Governance
Table 17: Genentech, Inc.: Financial Deals
Table 18: Genentech, Inc.: Market Developments
Table 19: Genentech, Inc.: Regulatory and Legal Events

List of Figures
Figure 1: Genentech, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Genentech, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Genentech, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Genentech, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Genentech, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Genentech, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Genentech, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Genentech, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bristol-Myers Squibb Co (BMY)-製薬・医療分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • Vifor Pharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Vifor Pharma AG (Vifor Pharma) a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tre …
  • Sernova Corp (SVA):企業の製品パイプライン分析2018
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • IXICO Plc (IXI)-製薬・医療分野:企業M&A・提携分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints. The company provides clinical trial services for assessing the safety and efficacy of drugs. Its product portfolio includes web-based platform to transf …
  • Grant Thornton International Ltd.:企業の戦略・SWOT・財務分析
    Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • CMC Biologics AS:製薬・医療:M&Aディール及び事業提携情報
    Summary CMC Biologics A/S (CMC Biologics), formerly CMC Biopharmaceuticals A/S, a subsidiary of Asahi Glass Co., Ltd., is a contract process development and manufacturer of biopharmaceuticals. The company's service portfolio encompasses process development, cGMP manufacturing, and quality and regula …
  • Wearable Health Solutions Inc (WHSI):医療機器:M&Aディール及び事業提携情報
    Summary Wearable Health Solutions Inc (Wearable Health Solutions), formerly Medical Alarm Concepts Holdings Inc, is a medical equipment manufacturing company that offers mobile health (mHealth) products and services. The company’s products include wearable healthcare products, medical alarm devices, …
  • Euroimmun AG:医療機器:M&Aディール及び事業提携情報
    Summary Euroimmun AG (Euroimmun), a subsidiary of PerkinElmer Inc is a medical device company that provides automation products. The company offers products such as indications, technical IIFT products, and automations. Its indications comprise auto-immune encephalitis, auto antibodies, anti-NMDA re …
  • IOI Corporation Berhad:企業の戦略・SWOT・財務分析
    IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務分析
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Penn Virginia Corp (PVAC):石油・ガス:M&Aディール及び事業提携情報
    Summary Penn Virginia Corp (Penn Virginia) is an independent oil and gas company. It explores, develops, and produces crude oil, Natural gas liquids (NGL), and natural gas. The company’s operations consist primarily of drilling unconventional horizontal development wells and operating producing well …
  • Phagelux Inc-製薬・医療分野:企業M&A・提携分析
    Summary Phagelux Inc (Phagelux) is an anti-infectives company that provides antibacterial products and solutions. The company uses phage lysis enzymes and biological agents for the treatment of antibiotic resistant bacteria and related diseases in human beings and crops. Its product portfolio includ …
  • Enel Americas SA:企業の戦略・SWOT・財務分析
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Rafael Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rafael Pharmaceuticals Inc (Rafael Pharmaceuticals), a subsidiary of IDT Corp is a healthcare products provider that offers therapeutics. The company develops drug therapies for the treatment of cancer. It provides altered energy metabolism directed platform for cancer cell energy metabolism …
  • Dillard’s Inc:戦略・SWOT・企業財務分析
    Dillard's Inc - Strategy, SWOT and Corporate Finance Report Summary Dillard's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • KCA Deutag Alpha Ltd:企業の戦略的SWOT分析
    KCA Deutag Alpha Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • L.L. Bean, Inc.:企業の戦略・SWOT・財務分析
    L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report Summary L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SouthGobi Resources Ltd:企業の戦略・SWOT・財務情報
    SouthGobi Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary SouthGobi Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Air Transport Services Group, Inc.:企業の戦略・SWOT・財務情報
    Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • N Brown Group plc:企業の戦略・SWOT・財務情報
    N Brown Group plc - Strategy, SWOT and Corporate Finance Report Summary N Brown Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆